Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol

Abstract
Background— An echocardiographic substudy of the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial was designed to test the ability of losartan to reduce left ventricular (L...

This publication has 24 references indexed in Scilit: